|
Post by kite on Mar 19, 2018 7:10:25 GMT -5
investors.mannkindcorp.com/news-releases/news-release-details/mannkind-announces-participation-hc-wainwright-annual-globalWESTLAKE VILLAGE, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation(Nasdaq:MNKD) focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, today announced it will be featured as a presenting company at the H.C. Wainwright Annual Global Life Sciences Conference at 1:45 PM (CET) on April 9, 2018. The conference is being held at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. Michael Castagna, Chief Executive Officer, of MannKind Corporation, will provide an overview of the Company's business during the live presentation and will participate in one-on-one meetings with investors who are registered to attend the conference. If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link (www.hcwevents.com ) to register for the conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company. The presentation will be webcast live. To access the webcast, please visit www.hcwevents.com. Interested parties can also access a link to the live webcast of the presentation from the News & Events section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 90 days following the live presentation.
|
|
|
Post by brotherm1 on Mar 19, 2018 8:52:50 GMT -5
Monte Carlo, big money!
|
|
|
Post by peppy on Mar 19, 2018 8:54:26 GMT -5
|
|
|
Post by hellodolly on Mar 19, 2018 9:00:20 GMT -5
investors.mannkindcorp.com/news-releases/news-release-details/mannkind-announces-participation-hc-wainwright-annual-globalWESTLAKE VILLAGE, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation(Nasdaq:MNKD) focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, today announced it will be featured as a presenting company at the H.C. Wainwright Annual Global Life Sciences Conference at 1:45 PM (CET) on April 9, 2018. The conference is being held at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. Michael Castagna, Chief Executive Officer, of MannKind Corporation, will provide an overview of the Company's business during the live presentation and will participate in one-on-one meetings with investors who are registered to attend the conference. If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link (www.hcwevents.com ) to register for the conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company. The presentation will be webcast live. To access the webcast, please visit www.hcwevents.com. Interested parties can also access a link to the live webcast of the presentation from the News & Events section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 90 days following the live presentation. In February, HC lowered their PT and placed MNKD as a Sell. The target is $1. This is an important conference for MNKD to attend.
|
|
|
Post by mnkdfann on Mar 19, 2018 9:11:27 GMT -5
|
|
|
Post by hellodolly on Mar 19, 2018 9:27:57 GMT -5
It was Maxim. My bad. I just look at my Finviz account. As to your second comment, that's entirely likely. That's how it would be played.
|
|
|
Post by goyocafe on Mar 19, 2018 9:29:17 GMT -5
Tells me they’re still in search of a partner. What term sheets? Sorry, didn’t sleep well last night.
|
|
|
Post by peppy on Mar 19, 2018 9:53:58 GMT -5
tells me they want to fly over to Monte Carlo and talk afrezza in front of a European audience. when I first read the release, I did not see the location. I thought a regular conference and I was surprised Kendall was not listed to co speak. Mike can handle it well. private conversations as well. investors. it makes sense in expansion possibilities.
In the mean time the SPX is presently down 29 points, money leaving US markets.
|
|
|
Post by mnholdem on Mar 19, 2018 9:54:23 GMT -5
Oppenhiemer tends to draw some larger investors as well. Michael Castagna, will present at the Oppenheimer 28th Annual Healthcare Conference on Tuesday, March 20, 2018 at 3:20 PM (Eastern Time).
Hmmm...I wonder what the odds are that Goldman-Sucks may be brought into play... That would make a few waves.
|
|
|
Post by buyitonsale on Mar 19, 2018 12:31:43 GMT -5
I hope Mike's recapitalization plan does not involve a roulette table
|
|
|
Post by peppy on Mar 19, 2018 12:58:04 GMT -5
I hope Mike's recapitalization plan does not involve a roulette table the irony is Rapid Acting Analog subq insulin, is a daily game of Roulette. www.screencast.com/t/D7yU20S2lo
|
|
|
Post by uvula on Mar 19, 2018 14:02:55 GMT -5
Anyone see 60 minutes? The prince of Saudi Arabia is looking for investment opportunities. And his country has a lot of diabetics. Hmmm.
|
|
|
Post by peppy on Mar 19, 2018 14:36:58 GMT -5
Anyone see 60 minutes? The prince of Saudi Arabia is looking for investment opportunities. And his country has a lot of diabetics. Hmmm. I saw it. I will be watching 60 minutes next week for the weather report as well. The interview you are referring too also asked the prince about his mother.
|
|
|
Post by sportsrancho on Mar 19, 2018 14:55:47 GMT -5
|
|
|
Post by agedhippie on Mar 19, 2018 15:09:49 GMT -5
HC Wainwright has a vested interest in taking Mannkind to Monte Carlo, they want to introduce them to European investors so they can sell them stock allocations and earn commission.
|
|